The Molecular Tango

How DNA and Peptides Dance Between Liquid and Solid States

Exploring phase transitions in oligonucleotide-peptide complexes

Article Navigation

Introduction
Key Concepts
Landmark Experiment
Therapeutic Applications
Synthesis Challenges
Scientist's Toolkit
Future Directions

The Phase Transition Revolution

Imagine microscopic blobs that shift between liquid and solid states like biological shape-shifters. This isn't science fiction—it's the cutting-edge science of oligonucleotide-peptide complexes, where genetic materials and protein fragments engage in an elegant molecular dance.

Recent breakthroughs reveal how these complexes control their physical state through DNA hybridization, a discovery with seismic implications for drug delivery, artificial cells, and understanding life's fundamental architecture ¹ ⁶ . At the heart of this phenomenon lies a simple switch: double-stranded DNA forms solids, while single-stranded chains create liquid droplets called coacervates. This article unravels how scientists harness this switch to program matter at the nanoscale.

DNA Hybridization

The process that drives phase transitions in these complexes.

Molecular Dance

The elegant interplay between DNA and peptides at nanoscale.

Phase Behavior Decoded

Charge Density & Counterion Release

When positively charged peptides (e.g., arginine-rich chains) meet negatively charged nucleic acids, they undergo electrostatic complexation. This releases counterions (Na⁺, Cl⁻), increasing entropy and driving phase separation. Double-stranded DNA's high charge density promotes solid precipitates, whereas floppy single strands form viscous liquids ¹ ⁶ .

The Salt Effect: A Molecular "Melter"

Adding salt disrupts electrostatic forces, "melting" solids into liquids. This environmental responsiveness enables smart nanoparticles that release drugs in high-salt environments like diseased tissues ¹ ⁴ .

The Landmark 2018 Experiment

Methodology: Engineering Phase Shifts

Researchers systematically mixed oligonucleotides (single/double-stranded DNA/RNA) with cationic peptides, varying:

Polymer lengths (5–50 nucleotides/amino acids)
Concentrations (0.1–10 mM)
Backbone chemistries (RNA vs. methylphosphonate DNA)
Salt gradients (0–500 mM NaCl) ¹ ⁶ .

Phase behavior was tracked using:

Fluorescence microscopy

(dye-labeled complexes)

Dynamic light scattering

(droplet size)

FRET assays

(hybridization in coacervates)

Results & Analysis: The Hybridization Switch

Solids to liquids: Adding 150 mM NaCl transformed precipitates into coacervates.
Functional droplets: Coacervates preserved oligonucleotide function—single strands inside droplets could still hybridize with complementary sequences, triggering phase shifts to solids ¹ .
Biological relevance: This mimics how cells form membraneless organelles (e.g., nucleoli) via liquid-liquid phase separation ⁶ .

Table 1: Phase Behavior vs. Nucleic Acid Structure
Nucleic Acid Type	Charge Density	Complex Phase
Double-stranded DNA	High	Solid precipitate
Single-stranded DNA	Low	Liquid coacervate
RNA duplexes	High	Solid precipitate
Methylphosphonate DNA	Moderate	Gel-like

Table 2: Salt-Induced Phase Transitions
NaCl Concentration	Double-Stranded DNA Complexes	Single-Stranded DNA Complexes
0 mM	Solid precipitate	Liquid coacervate
100 mM	Partially solubilized	Coacervate (stable)
300 mM	Fully liquid coacervate	Dissolved complex

Therapeutic Applications: From Labs to Clinics

Enhanced Drug Delivery

Peptide-oligonucleotide conjugates (POCs) leverage phase transitions:

Cell-penetrating peptides (CPPs) like Tat or penetratin ferry nucleic acids into cells. Optimal arginine content (8–10 residues) balances uptake and toxicity ⁴ ⁹ .
Coacervate encapsulation protects therapeutic oligonucleotides (e.g., siRNA) from degradation. Upon cellular entry, salt-triggered melting releases cargo ¹ ⁵ .

Targeted Tissue Delivery

GalNAc-conjugates direct oligonucleotides to liver cells, with 10× higher uptake than untargeted versions ⁵ .
Tumor-homing peptides (e.g., RGD motifs) exploit salt gradients in cancerous microenvironments to dissolve precipitates ⁴ .

Smart Drug Delivery Systems

The phase transition properties enable responsive drug delivery systems that can release therapeutics precisely where needed in the body, minimizing side effects and maximizing efficacy.

Synthesis Challenges: Building Molecular Hybrids

Parallel vs. Linear Assembly

Linear synthesis: One-pot solid-phase assembly. Efficient for short sequences but struggles with incompatible chemistries.

Parallel synthesis: Separately prepares peptides and oligonucleotides before conjugation. Higher purity for complex hybrids ³ .

Innovations in Conjugation Chemistry

Catalytic amide coupling: Uses DABCO/CDMT to link peptides to oligonucleotides in aqueous solutions, enabling DNA-encoded libraries .
High-purity reagents: Aurorium's Haelium™ Pyridine 900 (<30 ppm water) prevents side reactions during SPPS ² .

Table 3: Synthetic Strategies Compared
Method	Pros	Cons
Linear synthesis	Automated, single-step	Limited to compatible sequences
Parallel synthesis	Flexible, high-purity conjugates	Multi-step, lower yields

The Scientist's Toolkit: Essential Reagents

Table 4: Key Reagents for Oligonucleotide-Peptide Research
Reagent/Material	Function	Innovation
Haelium™ Piperidine 800	Deprotection in SPPS	Limits n-pentylamine impurities to <500 ppm
Haelium™ Lutidine 500	Oligonucleotide synthesis	Water content <100 ppm for color stability
CDMT/DABCO catalyst system	Aqueous-phase conjugation	Enables iterative POC synthesis
Cationic peptides (e.g., R₈)	Model phase behavior	Charge density control for coacervation
Fluorescent tags (Cy3/Cy5)	Track hybridization in coacervates	FRET confirms functional competence

Future Directions: Programmable Biomaterials

Dynamic Nanofactories

Coacervates that synthesize drugs in situ via enzyme-DNA complexes ¹ .

CRISPR-CPP Conjugates

Gene-editing complexes activated by phase transitions in target tissues ⁵ .

Neural Implants

Salt-responsive oligonucleotide gels for neurotransmitter release ⁶ .

"Phase control by hybridization isn't just chemistry—it's a new language for speaking to cells."

Lead researcher, 2018 JACS study ¹

The Phase Frontier

The marriage of oligonucleotides and peptides has birthed a new paradigm: materials that compute environmental cues through physical state changes. As TIDES 2025 and IOPC 2025 conferences highlight ⁷ ⁸ , this field is racing toward programmable therapeutics—drugs that morph from stable solids during storage to liquid releasers in diseased tissues. From correcting genetic errors to building artificial organelles, phase control by hybridization is rewriting the rules of molecular design.